CN101036691A - 一种用于提高骨密度及免疫力的保健品 - Google Patents
一种用于提高骨密度及免疫力的保健品 Download PDFInfo
- Publication number
- CN101036691A CN101036691A CN 200710014511 CN200710014511A CN101036691A CN 101036691 A CN101036691 A CN 101036691A CN 200710014511 CN200710014511 CN 200710014511 CN 200710014511 A CN200710014511 A CN 200710014511A CN 101036691 A CN101036691 A CN 101036691A
- Authority
- CN
- China
- Prior art keywords
- calcium
- immunity
- sample
- bone
- radix puerariae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000037182 bone density Effects 0.000 title claims abstract description 20
- 230000036039 immunity Effects 0.000 title claims abstract description 20
- 239000011575 calcium Substances 0.000 claims abstract description 52
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 49
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 49
- 230000036541 health Effects 0.000 claims abstract description 17
- 239000001506 calcium phosphate Substances 0.000 claims description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 11
- 235000011010 calcium phosphates Nutrition 0.000 claims description 11
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 11
- FGNPLIQZJCYWLE-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound OS(O)(=O)=O.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO FGNPLIQZJCYWLE-BTVCFUMJSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 9
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 18
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 230000006870 function Effects 0.000 abstract description 9
- 210000004698 lymphocyte Anatomy 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 210000002540 macrophage Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 4
- 206010065687 Bone loss Diseases 0.000 abstract description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 210000000845 cartilage Anatomy 0.000 abstract description 2
- 230000037406 food intake Effects 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 206010057249 Phagocytosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000008782 phagocytosis Effects 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 46
- 241001465754 Metazoa Species 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 21
- 210000000988 bone and bone Anatomy 0.000 description 19
- 210000000689 upper leg Anatomy 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 14
- 241000700159 Rattus Species 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 208000001132 Osteoporosis Diseases 0.000 description 8
- 229930003944 flavone Natural products 0.000 description 8
- 235000011949 flavones Nutrition 0.000 description 8
- 230000000242 pagocytic effect Effects 0.000 description 8
- 229910000019 calcium carbonate Inorganic materials 0.000 description 7
- 230000034994 death Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 206010013183 Dislocation of vertebra Diseases 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 5
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 5
- 235000008696 isoflavones Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 208000010392 Bone Fractures Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 210000002249 digestive system Anatomy 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 210000004988 splenocyte Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000006386 Bone Resorption Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 102000003390 tumor necrosis factor Human genes 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 241001295925 Gegenes Species 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000001994 activation Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- -1 aminoacid glucosamine salt Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000019254 respiratory burst Effects 0.000 description 2
- 238000002133 sample digestion Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000610361 Eurya Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 241000718543 Ormosia krugii Species 0.000 description 1
- DCTLJGWMHPGCOS-UHFFFAOYSA-N Osajin Chemical compound C1=2C=CC(C)(C)OC=2C(CC=C(C)C)=C(O)C(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DCTLJGWMHPGCOS-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000219781 Pueraria montana var. lobata Species 0.000 description 1
- OUZCFMSJGDEXRT-UHFFFAOYSA-N Scandinone Natural products O=C1C=2C(OC)=C(CC=C(C)C)C=3OC(C)(C)C=CC=3C=2OC=C1C1=CC=C(O)C=C1 OUZCFMSJGDEXRT-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000001845 splenic macrophage Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别(Ca:g/kg饲料) | 动物数(只) | 摄入钙(mg/3d) | 粪钙(mg/3d) | 表观吸收率 |
基础饲料组(1.50) | 10 | 107.7±28.76 | 6.31±1.05 | 93.95±1.04a |
碳酸钙对照组(3.03) | 10 | 152.6±16.93 | 60.46±11.59 | 60.51±5.73b |
0.17g/kg样品组(1.76) | 10 | 119.6±20.26 | 10.91±6.11 | 90.69±5.13a |
0.33g/kg样品组(2.01) | 10 | 104.0±27.56 | 28.08±10.42 | 73.15±5.30c |
1.00g/kg样品组(3.03) | 10 | 127.8±15.64 | 48.99±6.62 | 61.12±7.41b |
组别(Ca/kg饲料) | 动物数(只) | 股骨干重(g) | 股骨远心端骨密度(g/cm2) | 股骨中点骨密度(g/cm2) | 骨钙含量(mg/g) |
基础饲料组(1.50) | 10 | 0.80±0.03a | 0.189±0.012a | 0.160±0.013a | 208.5±17.68a |
碳酸钙对照组(3.03) | 10 | 0.85±0.03b | 0.232±0.012b | 0.201±0.015c | 252.8±13.30b |
0.17g/kg样品组(1.76) | 10 | 0.77±0.03a | 0.182±0.016a | 0.156±0.016a | 206.2±17.61a |
0.33g/kg样品组(2.01) | 10 | 0.83±0.03b | 0.212±0.015c | 0.188±0.017b | 238.5±11.60b |
1.00g/kg样品组(3.03) | 10 | 0.85±0.03b | 0.234±0.010b | 0.208±0.014c | 250.9±7.47b |
组别 | 动物数(只) | 抗体积数 |
对照 | 10 | 49.0±9.42 |
0.17g/kg | 10 | 49.8±8.45 |
0.33g/kg | 10 | 91.1±19.72* |
1g/kg | 10 | 138.7±25.70* |
组别 | 动物数(只) | 溶血空斑数(×103个/全脾) |
对照 | 10 | 9.5±2.17 |
0.17g/kg | 10 | 9.6±2.59 |
0.33g/kg | 10 | 12.0±3.16 |
1g/kg | 10 | 22.3±3.80* |
组别 | 动物数(只) | 胸腺指数(%) | 脾指数(%) |
对照 | 10 | 0.24±0.03 | 0.42±0.12 |
0.17g/kg | 10 | 0.23±0.03 | 0.44±0.07 |
0.33g/kg | 10 | 0.23±0.03 | 0.43±0.05 |
1g/kg | 10 | 0.24±0.04 | 0.45±0.07 |
组别 | 动物数(只) | 吞噬指数 |
对照 | 10 | 2.67±0.25 |
0.17g/kg | 10 | 2.87±0.34 |
0.33g/kg | 10 | 3.10±0.52* |
1g/kg | 10 | 3.74±0.12* |
组别 | 动物数(只) | 加ConA的OD值 | 不加ConA的OD值 | 差值OD值 |
对照 | 10 | 1.367±0.013 | 1.314±0.008 | 0.053±0.009 |
0.17g/kg | 10 | 1.369±0.015 | 1.314±0.011 | 0.055±0.010 |
0.33g/kg | 10 | 1.398±0.021* | 1.315±0.009 | 0.083±0.015* |
1g/kg | 10 | 1.501±0.018* | 1.319±0.009 | 0.182±0.017* |
组别 | 动物数(只) | 耳重均值(mg)右 | 耳重均值(mg)左 | 肿胀度(mg) |
对照 | 10 | 31.1±3.2 | 14.2±1.0 | 16.9±2.6 |
0.17g/kg | 10 | 32.3±2.9 | 14.3±1.1 | 18.0±3.0 |
0.33g/kg | 10 | 31.9±2.3 | 13.8±0.8 | 18.1±2.1 |
1g/kg | 10 | 32.7±2.8 | 14.1±1.1 | 18.6±2.8 |
组别 | 动物数(只) | NK细胞活性(%) |
对照 | 10 | 26.99±1.73 |
0.17g/kg | 10 | 29.27±1.75 |
0.33g/kg | 10 | 33.04±4.74* |
1g/kg | 10 | 33.44±3.18* |
组别 | 动物数(只) | 吞噬% | 吞噬指数 |
对照 | 10 | 11.0±1.8 | 0.164±0.03 |
0.17g/kg | 10 | 10.9±2.0 | 0.161±0.03 |
0.33g/kg | 10 | 13.4±2.3* | 0.205±0.04* |
1g/kg | 10 | 17.6±2.0* | 0.296±0.04* |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710014511A CN101036691B (zh) | 2007-04-11 | 2007-04-11 | 一种用于提高骨密度及免疫力的保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710014511A CN101036691B (zh) | 2007-04-11 | 2007-04-11 | 一种用于提高骨密度及免疫力的保健品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101036691A true CN101036691A (zh) | 2007-09-19 |
CN101036691B CN101036691B (zh) | 2010-05-19 |
Family
ID=38887998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710014511A Active CN101036691B (zh) | 2007-04-11 | 2007-04-11 | 一种用于提高骨密度及免疫力的保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101036691B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856128A (zh) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | 一种增加骨密度的保健食品及其制备方法 |
CN101947234A (zh) * | 2010-09-02 | 2011-01-19 | 南京威尔曼药物研究所 | 含有氨基葡萄糖制剂的制备方法及其应用 |
JP2012062279A (ja) * | 2010-09-16 | 2012-03-29 | Kyowa Hakko Bio Co Ltd | 直打用高単位グルコサミン顆粒 |
CN104824677A (zh) * | 2015-04-14 | 2015-08-12 | 贵阳德昌祥药业有限公司 | 一种增加骨密度的保健食品及其制备方法 |
CN104939054A (zh) * | 2014-03-26 | 2015-09-30 | 营养屋(成都)生物医药有限公司 | 一种增强骨密度及免疫力的保健食品及其制备方法 |
CN106072651A (zh) * | 2016-07-19 | 2016-11-09 | 山东明仁福瑞达制药股份有限公司 | 一种具有增加骨密度、抗炎镇痛作用的组合物及其制备方法 |
CN109078094A (zh) * | 2018-11-01 | 2018-12-25 | 苏州卫生职业技术学院 | 一种用于预防骨质疏松症的医药组合物及其制备方法 |
CN109078043A (zh) * | 2018-09-27 | 2018-12-25 | 广东环凯微生物科技有限公司 | 一种增加骨密度的葛根保健品及其制备方法 |
CN114532530A (zh) * | 2022-02-16 | 2022-05-27 | 浙江华方生命科技有限公司 | 一种初乳氨糖软骨素钙咀嚼片及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1509721A (zh) * | 2002-12-26 | 2004-07-07 | 孙家莉 | 用于防治骨退行性病变的含植物***和氨基葡萄糖的组合物及制备方法 |
CN1256967C (zh) * | 2003-01-30 | 2006-05-24 | 王晓 | 养生护肝药物及其制备方法 |
CN1284799C (zh) * | 2004-03-17 | 2006-11-15 | 广东省农业科学院农业生物技术研究所 | 一种葛根中提取高总黄酮含量淀粉的方法 |
-
2007
- 2007-04-11 CN CN200710014511A patent/CN101036691B/zh active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856128A (zh) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | 一种增加骨密度的保健食品及其制备方法 |
CN101856128B (zh) * | 2010-03-23 | 2014-06-18 | 无锡市天赐康生物科技有限公司 | 一种增加骨密度的保健食品及其制备方法 |
CN101947234A (zh) * | 2010-09-02 | 2011-01-19 | 南京威尔曼药物研究所 | 含有氨基葡萄糖制剂的制备方法及其应用 |
JP2012062279A (ja) * | 2010-09-16 | 2012-03-29 | Kyowa Hakko Bio Co Ltd | 直打用高単位グルコサミン顆粒 |
CN104939054A (zh) * | 2014-03-26 | 2015-09-30 | 营养屋(成都)生物医药有限公司 | 一种增强骨密度及免疫力的保健食品及其制备方法 |
CN104824677A (zh) * | 2015-04-14 | 2015-08-12 | 贵阳德昌祥药业有限公司 | 一种增加骨密度的保健食品及其制备方法 |
CN106072651A (zh) * | 2016-07-19 | 2016-11-09 | 山东明仁福瑞达制药股份有限公司 | 一种具有增加骨密度、抗炎镇痛作用的组合物及其制备方法 |
CN106072651B (zh) * | 2016-07-19 | 2019-08-23 | 山东明仁福瑞达制药股份有限公司 | 一种具有增加骨密度、抗炎镇痛作用的组合物及其制备方法 |
CN109078043A (zh) * | 2018-09-27 | 2018-12-25 | 广东环凯微生物科技有限公司 | 一种增加骨密度的葛根保健品及其制备方法 |
CN109078094A (zh) * | 2018-11-01 | 2018-12-25 | 苏州卫生职业技术学院 | 一种用于预防骨质疏松症的医药组合物及其制备方法 |
CN114532530A (zh) * | 2022-02-16 | 2022-05-27 | 浙江华方生命科技有限公司 | 一种初乳氨糖软骨素钙咀嚼片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101036691B (zh) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101036691B (zh) | 一种用于提高骨密度及免疫力的保健品 | |
CN103083650B (zh) | 一种具有增加骨密度功能的组合物及其制备方法和用途 | |
CN103251671B (zh) | 一种增加骨密度的含中药的组合物及其制备方法 | |
CN1301666C (zh) | 一种能增强免疫力的保健食品及其制备方法 | |
CN104162150A (zh) | 一种具有增加骨密度功能的组合物及其制备方法 | |
CN1457808A (zh) | 一种铁皮石斛复方制剂及制备和应用 | |
CN1824155A (zh) | 一种用于补肾的药物及其制备方法 | |
CN109276710A (zh) | 一种增加骨密度的组合物及其制备方法和用途 | |
CN105079028A (zh) | 一种改善骨关节的保健品及其制备方法 | |
CN108576816A (zh) | 一种增加骨密度的组合物 | |
CN101401833B (zh) | 一种预防和/或治疗骨质疏松症的组合物 | |
CN101292739B (zh) | 一种具有增加骨密度功能的保健食品 | |
CN1133450C (zh) | 一种预防和治疗骨质疏松及促进骨折愈合的药物及其生产方法 | |
CN100340245C (zh) | 壮骨口服液及其制备方法 | |
CN109170916A (zh) | 一种强身健体食品组合物及其制备方法 | |
CN1105198A (zh) | 猪用复合饲料添加剂及其制造方法 | |
CN1270624C (zh) | 一种花粉、蜂王浆食品及其制备方法 | |
CN101167754A (zh) | 海洋骨原肽作为制备预防骨质疏松药物、保健食品或食品的用途 | |
CN103156889A (zh) | 一种增强骨密度胶囊及其制备方法 | |
CN105639351A (zh) | 一种具有预防及治疗骨质疏松症的鳄鱼骨肽饮品 | |
CN1857561A (zh) | 一种治疗骨质疏松症的药物及其制备方法 | |
CN101690589B (zh) | 一种增加骨密度的保健品及其制备方法 | |
CN1239103C (zh) | 营养保健食品及其制法 | |
CN1258538A (zh) | 治疗糖尿病和高血脂的蚕保健食品及其制备方法 | |
CN101156849A (zh) | 一种促牙周再生的苯妥英钠缓释凝胶及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JINAN LAOLAISHOU BIO-TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG JINHUA Effective date: 20100527 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250101 202, BUILDING A, QILU SOFTWARE PARK, LIXIA DISTRICT, JINAN CITY, SHANDONG PROVINCE TO: 250101 ROOM 0604, BUILDING 9, SHUNTAI PLAZA, NO.2000, SHUNHUA ROAD, NEW+HIGH-TECH ZONE, JINAN CITY HANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100527 Address after: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Applicant after: Jinan Laolaishou Biological Technology Co., Ltd. Address before: 250101 A, block 202, Qilu Software Park, Lixia District, Shandong, Ji'nan Applicant before: Zhang Jinhua |
|
ASS | Succession or assignment of patent right |
Owner name: JINAN LAOLAISHOU BIOLOGY CO., LTD. Free format text: FORMER OWNER: JINAN LAOLAISHOU BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20100820 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100820 Address after: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee after: Jinan Laolaishou Biology Co., Ltd. Address before: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee before: Jinan Laolaishou Biological Technology Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee after: Jinan Laolaishou Biological Co., Ltd. Address before: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee before: Jinan Laolaishou Biology Co., Ltd. |
|
CP02 | Change in the address of a patent holder |
Address after: 250101 Shandong Province Jinan High-tech Zone Xinlu Street 1666 Sanqing Qisheng Square 5 Floor 8 Patentee after: Jinan Laolaishou Biological Co., Ltd. Address before: 250101 Shandong city of Ji'nan province high tech Zone Shun Road No. 2000 Shun Tai Plaza Building 9, room 0604 Patentee before: Jinan Laolaishou Biological Co., Ltd. |
|
CP02 | Change in the address of a patent holder |